End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
22.17
CNY
|
+1.28%
|
|
+16.19%
|
+16.68%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,387
|
12,059
|
13,082
|
9,534
|
11,945
|
-
|
-
|
Enterprise Value (EV)
1 |
5,387
|
12,059
|
13,082
|
9,534
|
11,945
|
11,945
|
11,945
|
P/E ratio
|
33.1
x
|
32.8
x
|
17.6
x
|
12.5
x
|
12.9
x
|
9.37
x
|
6.68
x
|
Yield
|
-
|
-
|
-
|
5.26%
|
3.97%
|
5.19%
|
7.62%
|
Capitalization / Revenue
|
-
|
4.77
x
|
3.79
x
|
2.21
x
|
2.3
x
|
2.01
x
|
1.56
x
|
EV / Revenue
|
-
|
4.77
x
|
3.79
x
|
2.21
x
|
2.3
x
|
2.01
x
|
1.56
x
|
EV / EBITDA
|
-
|
-
|
10.2
x
|
7.16
x
|
7.18
x
|
6.1
x
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
3.39
x
|
3.13
x
|
-
|
1.95
x
|
1.77
x
|
1.48
x
|
Nbr of stocks (in thousands)
|
488,423
|
488,423
|
501,813
|
501,785
|
538,777
|
-
|
-
|
Reference price
2 |
11.03
|
24.69
|
26.07
|
19.00
|
22.17
|
22.17
|
22.17
|
Announcement Date
|
2/9/21
|
4/12/22
|
3/30/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
2,530
|
3,447
|
4,320
|
5,196
|
5,948
|
7,661
|
EBITDA
1 |
-
|
-
|
1,283
|
1,332
|
1,663
|
1,958
|
-
|
EBIT
1 |
-
|
438.4
|
969.2
|
971.2
|
1,169
|
1,520
|
2,237
|
Operating Margin
|
-
|
17.33%
|
28.11%
|
22.48%
|
22.5%
|
25.55%
|
29.2%
|
Earnings before Tax (EBT)
1 |
-
|
435.9
|
944.6
|
965.9
|
1,168
|
1,520
|
2,237
|
Net income
1 |
142.6
|
367.8
|
757.8
|
766.4
|
934.1
|
1,234
|
1,799
|
Net margin
|
-
|
14.54%
|
21.98%
|
17.74%
|
17.98%
|
20.75%
|
23.48%
|
EPS
2 |
0.3334
|
0.7530
|
1.483
|
1.521
|
1.720
|
2.365
|
3.320
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
1.000
|
0.8800
|
1.150
|
1.690
|
Announcement Date
|
2/9/21
|
4/12/22
|
3/30/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
11.5%
|
19.1%
|
16.4%
|
15.2%
|
18.9%
|
22.2%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
7.47%
|
6.91%
|
7.5%
|
9.39%
|
11.9%
|
Assets
1 |
-
|
-
|
10,138
|
11,088
|
12,455
|
13,151
|
15,118
|
Book Value Per Share
2 |
-
|
7.290
|
8.340
|
-
|
11.40
|
12.50
|
15.00
|
Cash Flow per Share
2 |
-
|
0.1600
|
1.080
|
1.050
|
2.320
|
2.950
|
3.200
|
Capex
1 |
-
|
-
|
1,803
|
757
|
830
|
768
|
830
|
Capex / Sales
|
-
|
-
|
52.3%
|
17.52%
|
15.97%
|
12.9%
|
10.83%
|
Announcement Date
|
2/9/21
|
4/12/22
|
3/30/23
|
3/28/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +16.68% | 1.65B | | +5.97% | 105B | | -4.19% | 63.99B | | +51.90% | 42.95B | | +17.44% | 39.2B | | +6.62% | 33.01B | | +13.00% | 20.33B | | +15.64% | 17.29B | | +22.55% | 15.72B | | +7.34% | 14.72B |
Other Commodity Chemicals
|